<?xml version='1.0' encoding='utf-8'?>
<document id="11009047"><sentence text="Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects."><entity charOffset="19-30" id="DDI-PubMed.11009047.s1.e0" text="mirtazapine" /><entity charOffset="35-45" id="DDI-PubMed.11009047.s1.e1" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.11009047.s1.e0" e2="DDI-PubMed.11009047.s1.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s1.e0" e2="DDI-PubMed.11009047.s1.e1" /></sentence><sentence text="The objective of this study was to examine the pharmacokinetics and the tolerability/safety of mirtazapine and cimetidine separately and in combination following oral administration of multiple doses"><entity charOffset="95-106" id="DDI-PubMed.11009047.s2.e0" text="mirtazapine" /><entity charOffset="111-121" id="DDI-PubMed.11009047.s2.e1" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.11009047.s2.e0" e2="DDI-PubMed.11009047.s2.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s2.e0" e2="DDI-PubMed.11009047.s2.e1" /></sentence><sentence text="" /><sentence text="This was a double-blind, placebo-controlled, two-period cross-over, multiple-dose pharmacokinetic interaction study in 12 healthy male subjects" /><sentence text=" They received either cimetidine (800 mg b"><entity charOffset="22-32" id="DDI-PubMed.11009047.s5.e0" text="cimetidine" /></sentence><sentence text="i" /><sentence text="d" /><sentence text=") or placebo in combination with (commercially available, racemic) mirtazapine (30 mg nocte)"><entity charOffset="67-78" id="DDI-PubMed.11009047.s8.e0" text="mirtazapine" /></sentence><sentence text=" Cimetidine and placebo were administered for 14 days, with mirtazapine added during days 6-12 of each period"><entity charOffset="1-11" id="DDI-PubMed.11009047.s9.e0" text="Cimetidine" /><entity charOffset="60-71" id="DDI-PubMed.11009047.s9.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.11009047.s9.e0" e2="DDI-PubMed.11009047.s9.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s9.e0" e2="DDI-PubMed.11009047.s9.e1" /></sentence><sentence text=" Serial blood samples for kinetic profiling were taken on day 5 and day 12 for cimetidine and on days 12-14 for mirtazapine"><entity charOffset="79-89" id="DDI-PubMed.11009047.s10.e0" text="cimetidine" /><entity charOffset="112-123" id="DDI-PubMed.11009047.s10.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.11009047.s10.e0" e2="DDI-PubMed.11009047.s10.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s10.e0" e2="DDI-PubMed.11009047.s10.e1" /></sentence><sentence text="" /><sentence text="The co-administration of cimetidine resulted in a statistically significant increase in the area under the curve (AUC(0-24)) and Cmax of mirtazapine (54% and 22% respectively)"><entity charOffset="25-35" id="DDI-PubMed.11009047.s12.e0" text="cimetidine" /><entity charOffset="137-148" id="DDI-PubMed.11009047.s12.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.11009047.s12.e0" e2="DDI-PubMed.11009047.s12.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s12.e0" e2="DDI-PubMed.11009047.s12.e1" /></sentence><sentence text=" The AUC(0-24) of demethylmirtazapine increased only slightly, and there was no effect on Cmax"><entity charOffset="18-37" id="DDI-PubMed.11009047.s13.e0" text="demethylmirtazapine" /></sentence><sentence text=" The elimination half-lives for both mirtazapine and its demethyl metabolite were unaffected by cimetidine co-administration"><entity charOffset="37-48" id="DDI-PubMed.11009047.s14.e0" text="mirtazapine" /><entity charOffset="57-65" id="DDI-PubMed.11009047.s14.e1" text="demethyl" /><entity charOffset="96-106" id="DDI-PubMed.11009047.s14.e2" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.11009047.s14.e0" e2="DDI-PubMed.11009047.s14.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s14.e0" e2="DDI-PubMed.11009047.s14.e1" /><pair ddi="false" e1="DDI-PubMed.11009047.s14.e0" e2="DDI-PubMed.11009047.s14.e2" /><pair ddi="false" e1="DDI-PubMed.11009047.s14.e1" e2="DDI-PubMed.11009047.s14.e1" /><pair ddi="false" e1="DDI-PubMed.11009047.s14.e1" e2="DDI-PubMed.11009047.s14.e2" /></sentence><sentence text=" The trough and average plasma concentrations during the steady state were elevated during cimetidine treatment (62% and 54%, respectively)"><entity charOffset="91-101" id="DDI-PubMed.11009047.s15.e0" text="cimetidine" /></sentence><sentence text=" Mirtazapine had no effect on the pharmacokinetics of cimetidine"><entity charOffset="1-12" id="DDI-PubMed.11009047.s16.e0" text="Mirtazapine" /><entity charOffset="54-64" id="DDI-PubMed.11009047.s16.e1" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.11009047.s16.e0" e2="DDI-PubMed.11009047.s16.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s16.e0" e2="DDI-PubMed.11009047.s16.e1" /></sentence><sentence text="" /><sentence text="Co-administration of cimetidine (800 mg b"><entity charOffset="21-31" id="DDI-PubMed.11009047.s18.e0" text="cimetidine" /></sentence><sentence text="i" /><sentence text="d" /><sentence text=") and mirtazapine (30 mg nocte) resulted in increased steady-state plasma levels of mirtazapine (C(ss,min) = +61%, P &lt; 0"><entity charOffset="6-17" id="DDI-PubMed.11009047.s21.e0" text="mirtazapine" /><entity charOffset="84-95" id="DDI-PubMed.11009047.s21.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.11009047.s21.e0" e2="DDI-PubMed.11009047.s21.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s21.e0" e2="DDI-PubMed.11009047.s21.e1" /></sentence><sentence text="05; C(ss,av) = +54%, P &lt; 0" /><sentence text="05), probably as a result of increased bio-availability" /><sentence text=" The Cmax (+22%, P &lt; 0" /><sentence text="05) and AUC(0-24) (+54%, P &lt; 0"><entity charOffset="8-17" id="DDI-PubMed.11009047.s25.e0" text="AUC(0-24)" /></sentence><sentence text="05) also increased" /><sentence text=" Due to the variability of the mirtazapine plasma levels in patients, the clinical meaning of these increases is probably limited"><entity charOffset="31-42" id="DDI-PubMed.11009047.s27.e0" text="mirtazapine" /></sentence><sentence text=" Co-administration of mirtazapine did not alter cimetidine pharmacokinetics"><entity charOffset="22-33" id="DDI-PubMed.11009047.s28.e0" text="mirtazapine" /><entity charOffset="48-58" id="DDI-PubMed.11009047.s28.e1" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.11009047.s28.e0" e2="DDI-PubMed.11009047.s28.e0" /><pair ddi="false" e1="DDI-PubMed.11009047.s28.e0" e2="DDI-PubMed.11009047.s28.e1" /></sentence><sentence text="" /></document>